Mydecine Innovations Group Inc. (CSE:MYCO)

Canada flag Canada · Delayed Price · Currency is CAD
0.280
+0.030 (12.00%)
At close: Dec 3, 2025
12.00%
Market Cap 166.91K
Revenue (ttm) n/a
Net Income (ttm) 2.29M
Shares Out n/a
EPS (ttm) 1.85
PE Ratio 0.07
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 5,001
Average Volume 15,131
Open 0.280
Previous Close 0.250
Day's Range 0.280 - 0.280
52-Week Range 0.120 - 0.500
Beta 1.78
RSI 49.55
Earnings Date Mar 31, 2026

About CSE:MYCO

Mydecine Innovations Group Inc., a biotechnology company, engages in the research, development, and commercialization of psilocybin products to treat mental health conditions. The company primarily focuses on treating nicotine addiction and post-traumatic stress disorder. It also develops MYCO-005, MYCO-006, and MYCO-007 for MDMA and psilocybin analogs. The company has a partnership with Applied Pharmaceutical Innovation for pharmaceutical drug discovery, research, and development on empathogenic and entactogenic compounds. Mydecine Innovations... [Read more]

Sector Healthcare
Founded 2013
Employees 3
Stock Exchange Canadian Securities Exchange
Ticker Symbol MYCO
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.